Brief: Emerald Bioscience Announces Notice Of Allowance From United States Patent Office For Proprietary Analog Of Cannabidiol
09/03/2020 13:39
March 9 (Reuters) - Emerald Bioscience Inc EMBI.PK :
* EMERALD BIOSCIENCE ANNOUNCES NOTICE OF ALLOWANCE FROM
UNITED
STATES PATENT OFFICE FOR PROPRIETARY ANALOG OF CANNABIDIOL
Source text for Eikon: ID:nGNX7hg2b0
Further company coverage: EMBI.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Skye Bioscience
See all newsRCS - Redx Pharma Limited - Redx to Present Poster on RXC008 at UEG Week
RCS - Redx Pharma Limited - Redx Announces ROCKETEER Phase 2 Trial for RXC008
Brief: Skye Bioscience Says John Sharp Resigns As CFO - SEC Filing
Brief: Skye Bioscience - Enters $22 Million Securities Purchase Agreement With Redmile Biopharma Investments Iii - SEC Filing
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM